Fosun-Partnered COVID-19 Vaccine Approved in UK

Pfizer and Germany 's BioNTech announced their partnered mRNA COVID-19 vaccine has been approved for use in the UK , the first acceptance of a coronavirus vaccine in the west. Earlier, the vaccine was shown to be 95% effective in a large Phase II/III trial that enrolled 44,000 volunteers. Last month, Shanghai Fosun Pharma, which partners China rights to the candidate with BioNTech, started a Phase II bridging trial to determine whether China volunteers respond similarly to the vaccine as people in the west. More details.... Stock Symbols: (NYSE: PFE) (SHA: 600196; HK: 02196) Share this with colleagues: // //